Literature DB >> 33992554

Differences between First wave and Second wave of COVID-19 in India.

Vijay Kumar Jain1, Karthikeyan P Iyengar2, Raju Vaishya3.   

Abstract

Entities:  

Keywords:  COVID-19; First wave; Pandemics; SARS-CoV-2; Second wave

Mesh:

Year:  2021        PMID: 33992554      PMCID: PMC8106236          DOI: 10.1016/j.dsx.2021.05.009

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


× No keyword cloud information.
Sir The recent wave of corona virus is spreading like a ‘tsunami’ in India. As on April 23, 2021, the COVID-19 cases have crossed the 15.9 million, with 1,85,000 deaths. The 2nd wave is evolving at a phenomenal speed as compared to the 1st wave. There could be several factors responsible for the increased number of cases in the second wave. It is observed that the mutant virus has more effective transmission capability and its incubation period is also lesser. There has been a widespread disregard to the ‘Covid Appropriate Behaviours or CAB’ by the public and the quality of masks used are highly variable. N-95 masks are not much favored masks in India, due to their higher costs and the majority public are using either the indigenous masks made of clothes or are repeatedly using the same and worn out masks. The sharp rise can also be attributed to the higher testing; but, the doubts have been raised about the quality of testing as several cases of positive Covid-19 symptoms are reported as negative on the RT-PCR test. There are several obvious differences in the first and the second wave (Table 1 ). In the 2nd wave the paediatric and younger individuals are getting infected, in addition to older ones [1]. The symptoms of COVID 2nd wave are also variable, especially gastrointestinal [2].
Table 1

Differences between the First and the Second wave of COVID-19 in India.

FIRST WAVESECOND WAVE
Causative organismSARS-Cov-2 virusSeveral mutants of SARS-Cov-2 virus
Knowledge about the diseaseLessMore
SymptomatologyMore related to respiratory systemNewer symptoms like Gastrointestinal etc. adding
PresentationMore severeLesser intense
Shortness of breathsLess cases with breathlessnessMore cases with breathlessness
Age profile of the patientsMore older populationMore younger population
ComorbiditiesPatients with comorbiditiesaffected moreLess
Drug availabilityAcute shortage and black marketingAvailable in the hospitals and pharmacies
Health care workers•Lesser trained people•Fear of acquiring infection•Not vaccinated•More trained increased•Lesser fear to acquire infection•Mostly vaccinated
Bed capacityLimitedEnhanced
Ventilator bedsLess than 25000Increased to more than 50000
Laboratory testingOnly one laboratory in January 2020More laboratories in Private and Government center
PPEScarcityPlenty one million PPE produced
VaccineNot availableThree approved vaccines available
Treatment affordability•Increased test price•Increased treatment cost and PPE•Markedly reduced test price•Reduced treatment cost and PPE
Oxygen requirement to the patientLessMore
Requirement of mechanical ventilationLessMore
Disease SpreadSlowerMuch faster
Plasma TherapyLimitedMuch more
Death rateHigherLower
Positivity rateLowerMuch higher
Differences between the First and the Second wave of COVID-19 in India.

Indian perspective

It has been stated that several factors could have led to rise in reproduction number (R0) in India. If the number of COVID-19 cases rises on day to day basis with the current phenomenal speed; there will be the exhaustion of resources and manpower. There is an acute shortage of hospital beds, oxygen supply, medicines, and ventilators across the country for COVID-19 patients. Although there is no significant percentage increase in the death rate in the second wave, but due to alarmingly high number of infections, the total death numbers are disappointingly high [3]. Therefore, there is an urgent need for temporary but timely establishment of the hospitals that can save thousands of lives. Since, there no end to this clamity visible in the near future, the population has to learn to live with it in the most careful and safe manner and follow the CAB strictly. It is obvious that the prevention is better than cure for this disease and all the possible measures such as engagement and participation of public in controlling the disease, strict implementation of COVID Appropriate Behaviors (i.e, social distancing, use of face masks, and hand sanitation), mini lockdowns, night curfews, micro containments, etc must be implemented and observed by the Public.

Author's statements

Contributors: KPI, VKJ and RV involved in writing the original draft of manuscript, literature search, planning, conduct and editing. VKJ involved in Conceptualization, literature search, review and editing. All authors approved the final draft.

Funding statement

The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Patient consent for publication

Not required.

Declaration of competing interest

None declared.
  38 in total

1.  Portable BiPAP machines in Covid: A saviour in second pandemic wave.

Authors:  Vikas Saini; Sanjay Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2022-06-15

2.  Collateral Impact on Patients of Liver Diseases in the Second COVID-19 Wave: A Retrospective Cohort Study.

Authors:  Chitranshu Vashishtha; Ankit Bhardwaj; Amita Diwaker; Shivakshi Sharma; Manoj K Sharma; Shiv Sarin
Journal:  Cureus       Date:  2022-05-31

3.  Epidemiology of the first and second waves of COVID-19 pandemic in Djibouti and the vaccination strategy developed for the response.

Authors:  Mohamed Elhakim; Saleh Banoita Tourab; Fatouma Salem; Reinhilde Van De Weerdt
Journal:  BMJ Glob Health       Date:  2022-06

4.  A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India.

Authors:  Sanjiv Jasuja; Gaurav Sagar; Anupam Bahl; Neharita Jasuja; Rajesh Chawla; Avdhesh Bansal; Manjit S Kanwar; Sudha Kansal; Nikhil Modi; Athar P Ansari; Viny Kantroo; Purnima Dhar; Chitra Chatterjee; Nitin Ghonge; Samir Tawakley; Shalini Verma
Journal:  Int J Nephrol       Date:  2022-06-02

5.  A cross-sectional study of COVID-19 outbreak in Indian population.

Authors:  Murugesan Arumugam; Raleena Begum Haja Najimudeen; Arya Vijayan; Bhuvaneshwari Sathyamoorthy; Prashant S Patole
Journal:  Ann Med Surg (Lond)       Date:  2022-04-01

Review 6.  AYUSH- 64: A potential therapeutic agent in COVID-19.

Authors:  Ashok Kumar Panda; Sarbeswar Kar; Amit Kumar Rai; B C S Rao; N Srikanth
Journal:  J Ayurveda Integr Med       Date:  2022-01-04

7.  Development and validation of prognostic scoring system for COVID-19 severity in South India.

Authors:  Vishnu Shankar; Pearlsy Grace Rajan; Yuvaraj Krishnamoorthy; Damal Kandadai Sriram; Melvin George; S Melina I Sahay; B Jagan Nathan
Journal:  Ir J Med Sci       Date:  2022-01-07       Impact factor: 2.089

Review 8.  Gender and genetic factors impacting COVID-19 severity.

Authors:  Jai Ranjan; Akshatha Ravindra; Baijayantimala Mishra
Journal:  J Family Med Prim Care       Date:  2021-11-29

Review 9.  Fragility and challenges of health systems in pandemic: lessons from India's second wave of coronavirus disease 2019 (COVID-19).

Authors:  Manzoor Ahmad Malik
Journal:  Glob Health J       Date:  2022-01-19

10.  DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.

Authors:  Sai Deepak Yaranagula; Venkata Krishna Chaitanya Koduri
Journal:  Int J Infect Dis       Date:  2021-07-29       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.